HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Revlon hire

This article was originally published in The Rose Sheet

Executive Summary

Carl Kooyoomjian appointed Exec VP, technical affairs and worldwide operations, effective immediately, Revlon announces June 26. Reporting to President and CEO Jack Stahl, Kooyoomjian will head global operations and research and development, firm says. Exec replaces Elias Hebeka, PhD, who is retiring at the end of the year. Kooyoomjian joins the company from Pacer International, a logistic company where he served as vice chairman. Prior to his career with Pacer, the exec was corporate VP and director for commercial products supply and manufacturing for the Coca-Cola company...

You may also be interested in...



Expanded Lung Cancer Claim For Lilly’s Cyramza Faces US FDA Scrutiny

Oncologic Drugs Advisory Committee will consider whether a statistically significant benefit on progression-free survival, but no survival advantage, is enough to secure a first-line lung cancer indication for ramucirumab.

Hunt On For New Chair Of UK Regulator

Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”

Perrigo Rolls Out US ProAir Rival

Perrigo has received US FDA approval for a generic version of Teva’s ProAir albuterol inhaler. The firm is immediately launching a “limited quantity” but is also ramping up production with partner Catalent to meet future demand.

UsernamePublicRestriction

Register

RS011327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel